Literature DB >> 17184692

Lung large cell carcinoma producing granulocyte-colony-stimulating factor.

Sachiko Hasegawa1, Takashi Suda, Koji Negi, Yoshinobu Hattori.   

Abstract

In recent years, tumors producing granulocyte-colony-stimulating factor have been reported in an increasing number of patients, the majority of which have lung cancer. We experience a case of lung carcinoma producing granulocyte-colony-stimulating factor treated by resection and chemotherapy. He remains well 2 years and 10 months after surgery, with no recurrence of the carcinoma.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17184692     DOI： 10.1016/j.athoracsur.2006.04.049

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  8 in total

1.  Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells.

Authors:  Asaf Spiegel; Mary W Brooks; Samin Houshyar; Ferenc Reinhardt; Michele Ardolino; Evelyn Fessler; Michelle B Chen; Jordan A Krall; Jasmine DeCock; Ioannis K Zervantonakis; Alexandre Iannello; Yoshiko Iwamoto; Virna Cortez-Retamozo; Roger D Kamm; Mikael J Pittet; David H Raulet; Robert A Weinberg
Journal:  Cancer Discov       Date:  2016-04-12       Impact factor: 39.397

Review 2.  Metastasis as a systemic disease: molecular insights and clinical implications.

Authors:  Maša Alečković; Sandra S McAllister; Kornelia Polyak
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-06-14       Impact factor: 10.680

3.  Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes.

Authors:  Marcin Kowanetz; Xiumin Wu; John Lee; Martha Tan; Thijs Hagenbeek; Xueping Qu; Lanlan Yu; Jed Ross; Nina Korsisaari; Tim Cao; Hani Bou-Reslan; Dara Kallop; Robby Weimer; Mary J C Ludlam; Joshua S Kaminker; Zora Modrusan; Nicholas van Bruggen; Franklin V Peale; Richard Carano; Y Gloria Meng; Napoleone Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-16       Impact factor: 11.205

4.  G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models.

Authors:  Farbod Shojaei; Xiumin Wu; Xueping Qu; Marcin Kowanetz; Lanlan Yu; Martha Tan; Y Gloria Meng; Napoleone Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-03       Impact factor: 11.205

5.  Granulocyte-colony stimulating factor (G-CSF)-producing esophageal squamous cell carcinoma: a case report.

Authors:  Takeshi Shimakawa; Shinichi Asaka; Atsuko Usuda; Kentaro Yamaguchi; Kazuhiko Yoshimatsu; Shunichi Shiozawa; Takao Katsube; Yoshihiko Naritaka
Journal:  Int Surg       Date:  2014 May-Jun

6.  Systemic chemotherapy with pronounced efficacy and neutropenia in a granulocyte-colony stimulating factor-producing advanced gastric neuroendocrine carcinoma.

Authors:  Nobuhiro Tsuruta; Kotoe Takayoshi; Shuji Arita; Tomomi Aikawa; Hiroshi Ariyama; Hitoshi Kusaba; Kenoki Ohuchida; Eishi Nagai; Kenichi Kohashi; Minako Hirahashi; Kyoko Inadomi; Mamoru Tanaka; Kosuke Sagara; Yuta Okumura; Kenta Nio; Michitaka Nakano; Masafumi Nakamura; Yoshinao Oda; Koichi Akashi; Eishi Baba
Journal:  Oncol Lett       Date:  2017-06-02       Impact factor: 2.967

7.  Granulocyte Colony-Stimulating Factor Treatment During Radiotherapy Is Associated With Survival Benefit in Patients With Lung Cancer.

Authors:  Rui Du; Pingping Hu; Qiqi Liu; Jingxin Zhang; Guodong Deng; Dan Hu; Jiandong Zhang
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

8.  Granulocyte-colony stimulating factor producing rectal cancer.

Authors:  Hiroki Takahashi; Akira Yasuda; Nubuo Ochi; Masaki Sakamoto; Satoru Takayama; Takehiro Wakasugi; Hitoshi Funahashi; Hirozumi Sawai; Mikinori Satoh; Yoshimi Akamo; Hiromitsu Takeyama
Journal:  World J Surg Oncol       Date:  2008-06-29       Impact factor: 2.754
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.